Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
TELA Bio, Inc. (TELA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Firestone Gregory A. (Chief Business Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 17,950 shares
@ $0 |
|
| 06/02/2023 |
4
| O'Brien Federica F. (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 06/02/2023 |
4
| COLLERAN LISA N (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 06/02/2023 |
4
| EVANS DOUGLAS G (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 06/02/2023 |
4
| Azarbarzin Kurt (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 06/02/2023 |
4
| Nosenzo John (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 06/02/2023 |
4
| Burgess Vincent J (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| KOBLISH ANTONY (CEO) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Paid exercise price by delivering 385 shares
@ $10.64, valued at
$4.1k
|
|
| 04/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Murphy Peter C. (Chief Commercial Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Paid exercise price by delivering 163 shares
@ $10.64, valued at
$1.7k
|
|
| 04/04/2023 |
4
| Talmo Paul (Chief Strategic Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Paid exercise price by delivering 187 shares
@ $10.64, valued at
$2k
|
|
| 03/31/2023 |
4
| Burgess Vincent J (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Exercised 4,860 options to buy
@ $4.44, valued at
$21.6k
|
|
| 02/27/2023 |
4
| Cuca Roberto (COO and CFO) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 17,700 shares
@ $0
Paid exercise price by delivering 1,300 shares
@ $10.5, valued at
$13.7k
Granted 27,700 options to buy
@ $10.5, valued at
$290.9k
|
|
| 02/27/2023 |
4
| Murphy Peter C. (Chief Commercial Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 16,800 shares
@ $0
Paid exercise price by delivering 906 shares
@ $10.5, valued at
$9.5k
Paid exercise price by delivering 940 shares
@ $11.03, valued at
$10.4k
Granted 26,400 options to buy
@ $10.5, valued at
$277.2k
|
|
| 02/27/2023 |
4
| Talmo Paul (Chief Strategic Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 16,800 shares
@ $0
Paid exercise price by delivering 1,067 shares
@ $10.5, valued at
$11.2k
Paid exercise price by delivering 1,032 shares
@ $11.03, valued at
$11.4k
Granted 26,400 options to buy
@ $10.5, valued at
$277.2k
|
|
| 02/27/2023 |
4
| KOBLISH ANTONY (CEO) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 61,200 shares
@ $0
Paid exercise price by delivering 6,034 shares
@ $11.03, valued at
$66.6k
Granted 96,100 options to buy
@ $10.5, valued at
$1M
|
|
| 02/27/2023 |
4
| Smeykal Megan (Chief Accounting Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Paid exercise price by delivering 423 shares
@ $10.5, valued at
$4.4k
Paid exercise price by delivering 539 shares
@ $11.03, valued at
$5.9k
|
|
| 02/23/2023 |
4
| Smeykal Megan (Chief Accounting Officer) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 9,400 shares
@ $0 |
|
| 11/04/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 19,000 shares
@ $7.8119, valued at
$148.4k
Bought 1,262 shares
@ $7.8119, valued at
$9.9k
|
|
| 10/11/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 15,000 shares
@ $8, valued at
$120k
Bought 1,000 shares
@ $8, valued at
$8k
|
|
| 09/26/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 6,500 shares
@ $7.9942, valued at
$52k
Bought 304 shares
@ $7.9942, valued at
$2.4k
|
|
| 09/19/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 17,000 shares
@ $8.088, valued at
$137.5k
Bought 1,000 shares
@ $8.088, valued at
$8.1k
|
|
| 09/16/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 3,500 shares
@ $8.1, valued at
$28.4k
Bought 658 shares
@ $8.1, valued at
$5.3k
Bought 2,000 shares
@ $8.0831, valued at
$16.2k
Bought 372 shares
@ $8.0831, valued at
$3k
|
|
| 09/15/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $8.0991, valued at
$40.5k
Bought 221 shares
@ $8.0991, valued at
$1.8k
|
|
| 08/19/2022 |
4
| EW HEALTHCARE PARTNERS FUND 2, L.P. (See footnote 2) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 500,000 shares
@ $8, valued at
$4M
|
|
| 08/16/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 300,000 shares
@ $8, valued at
$2.4M
Bought 15,000 shares
@ $8, valued at
$120k
|
|
| 08/12/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 11,500 shares
@ $8.5223, valued at
$98k
Bought 479 shares
@ $8.5223, valued at
$4.1k
|
|
| 08/02/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 4,500 shares
@ $7.9598, valued at
$35.8k
Bought 479 shares
@ $7.9598, valued at
$3.8k
|
|
| 07/22/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $8.021, valued at
$40.1k
Bought 200 shares
@ $8.021, valued at
$1.6k
|
|
| 07/21/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 9,500 shares
@ $8.0297, valued at
$76.3k
Bought 833 shares
@ $8.0768, valued at
$6.7k
|
|
| 07/20/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 4,500 shares
@ $8.0768, valued at
$36.3k
Bought 600 shares
@ $8.0768, valued at
$4.8k
|
|
| 07/13/2022 |
4
| EW HEALTHCARE PARTNERS FUND 2, L.P. (See footnote 2) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $8.02, valued at
$40.1k
Bought 5,000 shares
@ $8.02, valued at
$40.1k
Bought 5,000 shares
@ $8.03, valued at
$40.2k
|
|
|
|
|